Arrowpoint Asset Management LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:24 pm Purchase |
2024-09-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Arrowpoint Asset Management LLC | 3,647,291 7.080% |
933,148 (+34.38%) |
Filing |
| 2024-02-14 3:38 pm Purchase |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Arrowpoint Asset Management LLC | 2,714,143 5.310% |
2,714,143 (New Position) |
Filing |